Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

Modifi Biosciences is acquired by Merck

Summary by Union News Daily
Dr. Ranjit S. Bindra, Modifi Biosciences co-founder RAHWAY, NJ — Modifi Biosciences Inc., a leader in the development of direct DNA modification enabled cancer therapeutics, has been recently acquired by Merck and Co. Inc. Modifi Biosciences, a Yale University spinout company formed in 2021, has developed a novel class of small molecules that target cancer cells lacking express of a key DNA repair protein called O⁶-Methylguanine-DNA Methyltransf…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

MerckMerck
United StatesUnited States
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal